Notice of Thirty- Third(33rd) Annual General Meeting of the Company Scheduled to be held on Friday, September 26, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech has called its 33rd AGM on Friday, September 26, 2025 at 3:00 PM via video conferencing, to consider adoption of FY25 audited financials, declaration of a final dividend of Rs. 2 per equity share (face value Rs. 10) — aggregating to Rs. 165.274 lakh on 82,63,700 shares — and re-appointment of three directors (Manju, Raja, and Udit Singla) retiring by rotation. Shareholders will also vote on re-appointing both Managing Directors — Naresh Kumar Singla and Suresh Chand Singla — for a fresh 5-year term from April 1, 2026 to March 31, 2031, each with a starting salary of Rs. 8 lakh per month (ceiling Rs. 20 lakh). Two Whole Time Directors (Shivom Singla and Udit Singla) are getting a pay hike from Rs. 10 lakh to Rs. 13.5 lakh per month. Other agenda items include approving loans up to Rs. 12 crore to group entities, mortgage authorization for borrowings up to Rs. 25 crore, appointment of a new Secretarial Auditor for 5 years, regularization of an Independent Director, and approval of material related party transactions with Phoenix Bio Sciences, Peptech Biosciences, and Stalwart Nutritions.
Routine procedural AGM with a modest confirmed dividend; the multiple director re-appointments and pay hikes for promoter-family directors (alongside related party transactions with three group firms) are notable and should be reviewed closely by shareholders before voting. Net stock-price impact is likely neutral in the short term.